This site is intended for healthcare professionals
News

Four-week dosing now approved in all Imfinzi indications, reducing medical visits and improving patient convenience.- AstraZeneca

Read time: 1 mins
Last updated:21th Nov 2020
Published:21th Nov 2020
Condition: Non Small Cell Lung Cancer
Type: drug
Register free for full access to medthority.com